Lucid Diagnostics Inc. (NASDAQ: LUCD)
$0.87
-0.0070 ( -0.80% ) 89.9K
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Market Data
Open
$0.87
Previous close
$0.88
Volume
89.9K
Market cap
$45.85M
Day range
$0.87 - $0.93
52 week range
$0.63 - $1.72
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jun 21, 2024 |
def | Proxies and info statements | 3 | Jun 06, 2024 |
8-k | 8K-related | 13 | May 24, 2024 |
pre | Proxies and info statements | 3 | May 24, 2024 |
8-k | 8K-related | 14 | May 14, 2024 |
10-q | Quarterly Reports | 77 | May 13, 2024 |
4 | Insider transactions | 1 | May 09, 2024 |
3 | Insider transactions | 1 | May 09, 2024 |
4 | Insider transactions | 1 | May 08, 2024 |
4 | Insider transactions | 1 | May 08, 2024 |